Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose).
Do, D V
Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose). [electronic resource] - Eye (London, England) Dec 2015 - 1538-44 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1476-5454
10.1038/eye.2015.142 doi
Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors--administration & dosage
Diabetic Retinopathy--diagnosis
Double-Blind Method
Female
Follow-Up Studies
Humans
Intravitreal Injections
Macular Edema--diagnosis
Male
Middle Aged
Ranibizumab--administration & dosage
Retina--pathology
Tomography, Optical Coherence
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose). [electronic resource] - Eye (London, England) Dec 2015 - 1538-44 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1476-5454
10.1038/eye.2015.142 doi
Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors--administration & dosage
Diabetic Retinopathy--diagnosis
Double-Blind Method
Female
Follow-Up Studies
Humans
Intravitreal Injections
Macular Edema--diagnosis
Male
Middle Aged
Ranibizumab--administration & dosage
Retina--pathology
Tomography, Optical Coherence
Vascular Endothelial Growth Factor A--antagonists & inhibitors